Latest Insights on DIS
![](https://cdn.banyanhill.com/wp-content/uploads/2019/06/27142733/copper-image-440x264.jpg)
June 28, 2019 American Investor Today, Investment Opportunities, Natural Resources
The threat of a global trade war, an economic slowdown and a bear market for metals have caused copper prices to remain low. But Anthony Planas sees low copper prices as an opportunity to profit from the inevitable surge in copper stocks this year. (2-minute read)![](https://cdn.banyanhill.com/wp-content/uploads/2019/06/26142623/shutterstock_278904245-440x264.jpg)
June 27, 2019 Investment Opportunities, Stocks, Winning Investor Daily
I decided to research which stocks in the S&P 500 Index did the best during the past four rate cuts. You’ll be interested to learn what I found…![Great Stuff 6-27-2019](https://cdn.banyanhill.com/wp-content/uploads/2019/06/27133223/Great-Stuff-6-27-2019-Small.jpg)
June 27, 2019 Great Stuff
Today, we’re not going to talk about Trump, China or the Democratic debates. You’re welcome. The reason: I’m plumb Xi’ed out. I’ve got no more Trump in the tank, and it’s far too early to worry about what the two million candidates running for the Democratic nomination are debating right now. Besides, bitcoin (CCC: BTC-USD) […]![Big Data companies make billions of dollars of profits every quarter by exploiting data that they’ve taken from us without any compensation.](https://cdn.banyanhill.com/wp-content/uploads/2019/06/25114756/shutterstock_650551144-440x264.jpg)
June 26, 2019 Privacy Invasion, Technology, Winning Investor Daily
Big Data companies make billions of dollars of profits every quarter by exploiting data that they’ve taken from us without any compensation.![Great Stuff 06-25-2019](https://cdn.banyanhill.com/wp-content/uploads/2019/06/25152935/GS-192506-Small.jpg)
June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]